Adrenal Dysfunction in Mitochondrial Diseases
International Journal of Molecular Sciences · 06.01.2023 · 24 (2) · 1126
DOI: 10.3390/ijms24021126 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.01.2023. Verfasst von Madeleine Corkery-Hayward und 1 weiteren Autor:innen. Beteiligte Einrichtung: Barts and the London Medical School, Queen Mary University of London, London E1 2AD, UK. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Adrenal Gland Diseases, Adrenal Insufficiency. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Wellcome Trust, Barts Charity.
Abstract (Originalsprache)
Cortisol is central to several homeostatic mechanisms including the stress and immune response. Adrenal insufficiency and impaired cortisol production leads to severe, potentially fatal disorders. Several fundamental stages of steroidogenesis occur within the mitochondria. These dynamic organelles not only contribute ATP for steroidogenesis, but also detoxify harmful by-products generated during cortisol synthesis (reactive oxygen species). Mutations in nuclear or mitochondrial DNA that impair mitochondrial function lead to debilitating multi-system diseases. Recently, genetic variants that impair mitochondrial function have been identified in people with isolated cortisol insufficiency. This review aimed to clarify the association between mitochondrial diseases and adrenal insufficiency to produce cortisol. Mitochondrial diseases are rare and mitochondrial diseases that feature adrenal insufficiency are even rarer. We identified only 14 cases of adrenal insufficiency in people with confirmed mitochondrial diseases globally. In line with previous reviews, adrenal dysfunction was most prevalent in mitochondrial deletion syndromes (particularly Pearson syndrome and Kearns–Sayre syndrome) and with point mutations that compromised oxidative phosphorylation. Although adrenal insufficiency has been reported with mitochondrial diseases, the incidence reflects that expected in the general population. Thus, it is unlikely that mitochondrial mutations alone are responsible for an insufficiency to produce cortisol. More research is needed into the pathogenesis of adrenal disease in these individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Barts and the London Medical School, Queen Mary University of London, London E1 2AD, UK.
- Centre for Endocrinology, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, UK.
ORCID-Profile: Louise A Metherell
Förderung
- Medical Research Council
- Wellcome Trust
- Barts Charity
Zitieren
APA
Corkery-Hayward, M., & Metherell, L. A. (2023). Adrenal Dysfunction in Mitochondrial Diseases. International Journal of Molecular Sciences, 24(2), 1126. https://doi.org/10.3390/ijms24021126
Vancouver
Corkery-Hayward M, Metherell LA. Adrenal Dysfunction in Mitochondrial Diseases. International Journal of Molecular Sciences. 2023;24(2):1126. doi:10.3390/ijms24021126
BibTeX
@article{CorkeryHayward2023,
author = {Corkery-Hayward, Madeleine and Metherell, Louise A},
title = {Adrenal Dysfunction in Mitochondrial Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {2},
pages = {1126},
doi = {10.3390/ijms24021126}
}
EUVIMED